trending Market Intelligence /marketintelligence/en/news-insights/trending/fyfjq3unaf7yw6dybdfdqw2 content esgSubNav
In This List

Wize Pharma shareholders approve reverse stock split

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Wize Pharma shareholders approve reverse stock split

Israel's Wize Pharma Inc. said its shareholders approved a reverse stock split at a Feb. 19 special meeting.

Under the company's amended certificate of incorporation, the board can effect a reverse stock split by a ratio between 1-for-10 and 1-for-200 at any time before Feb. 19, 2019.